Arcturus Therapeutics Ltd. — Form D

Arcturus Therapeutics Ltd. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-04. The offering totals $67.8M, of which $67.8M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2018-01-04
• Form: D
• Accession: 0001610618-18-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $67.8M
• Amount sold: $67.8M
• Investors: 82
• Date of first sale: 2017-11-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-302301

Issuer

• Name: Arcturus Therapeutics Ltd.
• CIK: 0001566049
• Entity type: Other
• Jurisdiction: ISRAEL
• Address: 10628 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
• Phone: 858-900-2660

Officers, directors & promoters (9)

More

• CIK 1566049 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search